Point-of-care Ultrasound to Assess Hydronephrosis in Patients With Acute Kidney Injury in the Emergency Department
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06040736 |
Recruitment Status :
Recruiting
First Posted : September 18, 2023
Last Update Posted : September 21, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Acute Kidney Injury Urinary Tract Obstruction |
Study Type : | Observational |
Estimated Enrollment : | 156 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Point-of-care Ultrasound to Assess Hydronephrosis in Patients Presenting With Acute Kidney Injury in the Emergency Department: a Prospective Comparative Pragmatic Study |
Actual Study Start Date : | July 2, 2020 |
Estimated Primary Completion Date : | September 30, 2023 |
Estimated Study Completion Date : | September 30, 2023 |
Group/Cohort |
---|
Patients with acute kidney injury
Emergency department patients presenting with acute kidney injury, regardless of their complaint for ED admission. AKI is defined based on increase in serum creatinine (SCr) levels according to Kdigo criteria Patients will undergo both a bedside point of care ultrasonography and a central radiology imaging evaluation of hydronephrosis as part of routine care
|
- Performance of pont of care ultrasound (POCUS) for the diagnosis of hydronephrosis [ Time Frame: 1 day (Emergency department (ED) length of stay) ]Performance of POCUS for the detection of hydronephrosis compared to radiology imaging as the gold standard (Sensitivity, Specificity, Negative Predictive Value, Positive Predicted Value)
- Level of agreement between ED Pocus and central radiology imaging for the diagnosis of hydronephrosis [ Time Frame: 1 day (ED length of stay) ]Agreement between Pocus and radiology examination (radiology ultrasound (US) or Computed Tomography (CT) for the diagnosis of hydronephrosis
- Risk Factors for POCUS misdiagnosis [ Time Frame: 1 day (ED length of stay) ]Factors associated with misdiagnosis of hydronephrosis at POCUS
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patient with acute kidney injury defined by changes in serum creatinine (sCr) level between the index sCr at ED admission and pre and/or post sCr controls (Kidney Disease Improving Global Outcome criteria)
- Patient who does not oppose to the use of their data
Exclusion Criteria:
- Vesical globe
- Polycystic kidney disease
- Known renal tumor
- Horseshoe kidney
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06040736
Contact: Mustapha SEBBANE, MD, PhD | +33 (4) 67 33 79 74 | m-sebbane@chu-montpellier.fr | |
Contact: Sophie LEFEBVRE, PhD | +33 (4) 67 33 85 76 | s-lefebvre@chu-montpellier.fr |
France | |
university hospital of Montpellier | Recruiting |
Montpellier, France |
Principal Investigator: | Mustapha SEBBANE, MD, PhD | University Hospital, Montpellier |
Responsible Party: | University Hospital, Montpellier |
ClinicalTrials.gov Identifier: | NCT06040736 |
Other Study ID Numbers: |
RECHMPL21_0158 |
First Posted: | September 18, 2023 Key Record Dates |
Last Update Posted: | September 21, 2023 |
Last Verified: | July 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Point-of-care ultrasound Acute kidney injury Hydronephrosis urinary tract obstruction Emergency Medicine |
Acute Kidney Injury Hydronephrosis Emergencies Wounds and Injuries Disease Attributes Pathologic Processes Renal Insufficiency |
Kidney Diseases Urologic Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Male Urogenital Diseases |